News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
CDMO Ajinomoto Althea is opening a new facility to offer outsourced ADC (antibody drug conjugate) and HPAPI (highly potent active pharmaceutical ingredient) manufacturing, the Californian company has announced.
Dispatches from CPhI Worldwide
Remsima will soon achieve total market dominance in Norway thanks to a 69% discount on J&J’s Remicade, the man behind a trial studying the impact of biosimilar switching says.
ABEC has begun supplying the Irish biopharma industry bioprocessing equipment from an ex-electronics facility in County Cork, acquired earlier this year.